» Articles » PMID: 22580334

Nanoparticles in Drug Delivery: Past, Present and Future

Overview
Specialty Pharmacology
Date 2012 May 15
PMID 22580334
Citations 143
Authors
Affiliations
Soon will be listed here.
Abstract

This opinion paper relates how nanoparticles were discovered in the seventies and how the development of biodegradable materials and nanoparticle surface functionalization has allowed new treatment strategies. The reasons why only very few nanoparticle-based medicines are on the market or in late clinical trials are discussed and some new approaches are identified. Future challenges in the nanoparticle field are also identified.

Citing Articles

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.


A comprehensive review on liraglutide and novel nanocarrier-based systems for the effective delivery of liraglutide.

Pandey A, Rath G, Chawala R, Goyal A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40014122 DOI: 10.1007/s00210-025-03918-1.


PUCHIK: A Python Package To Analyze Molecular Dynamics Simulations of Aspherical Nanoparticles.

Ishkhanyan H, Santana-Bonilla A, Lorenz C J Chem Inf Model. 2025; 65(4):1694-1701.

PMID: 39928985 PMC: 11863366. DOI: 10.1021/acs.jcim.4c02128.


Nanomedicine embraces the treatment and prevention of acute kidney injury to chronic kidney disease transition: evidence, challenges, and opportunities.

Li J, Duan J, Hua C, Pan S, Li G, Feng Q Burns Trauma. 2024; 12:tkae044.

PMID: 39678075 PMC: 11645459. DOI: 10.1093/burnst/tkae044.


Regenerative medicine: Hydrogels and mesoporous silica nanoparticles.

Pablos J, Lozano D, Manzano M, Vallet-Regi M Mater Today Bio. 2024; 29:101342.

PMID: 39649249 PMC: 11625165. DOI: 10.1016/j.mtbio.2024.101342.